Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $5.5 Million Public Offering of Common Stock of ENDRA Life Sciences Inc.
Press Release – New York, NY – December 18, 2020 – Sichenzia Ross Ference LLP announced today that it represented ThinkEquity, a division of Fordham Financial Management, as sole underwriter in the follow on public offering of the common stock of ENDRA Life Sciences (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. The offering consisted of 7,857,286 shares of common stock, and the gross proceeds from the offering were $5,500,100, before deducting underwriting discounts and estimated offering expenses.
A shelf registration statement on Form S-3 (File No. 333-229090) relating to the shares of common stock issued in the proposed offering was filed with the Securities and Exchange Commission (the “SEC”) and is effective.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, Barrett DiPaolo and associate Jacob Tabman.
- Sichenzia Ross Ference LLP Announces Over 80 Capital Markets Transactions Valued Over $2 Billion at the Closing of 2021 - January 13, 2022
- Sichenzia Ross Ference LLP Adds Two Key Additions to its Corporate and Securities Law Team - January 11, 2022
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd. - December 30, 2021